Showing results (601-610 of 4,140) with videos related to
Sort By:
Pageof 414
Molecular Carcinogenesis|December 17, 2017
The triterpenoid corosolic acid blocks transformation and epigenetically reactivates Nrf2 in TRAMP-C1 prostate cellsJie Yang, Renyi Wu, Wenji Li, et al.Molecular Carcinogenesis|September 24, 2017
ITIH5 induces a shift in TGF-β superfamily signaling involving Endoglin and reduces risk for breast cancer metastasis and tumor deathMichael Rose, Steffen K Meurer, Vera Kloten, et al.Molecular Carcinogenesis|September 20, 2017
Serum HOTAIR and GAS5 levels as predictors of survival in patients with glioblastomaJie Shen, Tiffany R Hodges, Renduo Song, et al.Molecular Carcinogenesis|September 20, 2017
TNFAIP8 regulates Hippo pathway through interacting with LATS1 to promote cell proliferation and invasion in lung cancerYong Han, ZhongPing Tang, Yue Zhao, et al.Molecular Carcinogenesis|September 7, 2017
Procyanidin B2 3,3″-di-O-gallate induces oxidative stress-mediated cell death in prostate cancer cells via inhibiting MAP kinase phosphatase activity and activating ERK1/2 and AMPKRahul Kumar, Gagan Deep, Michael F Wempe, et al.Molecular Carcinogenesis|September 13, 2017
p0071 interacts with E-cadherin in the cytoplasm so as to promote the invasion and metastasis of non-small cell lung cancerHuanyu Zhao, Di Zhang, Lianhe Yang, et al.Molecular Carcinogenesis|March 13, 2018
Multi-omics analysis identifies pathways and genes involved in diffuse-type gastric carcinogenesis induced by E-cadherin, p53, and Smad4 loss in miceJun Won Park, Min-Sik Kim, Dominic C Voon, et al.Molecular Carcinogenesis|January 12, 2018
Differentiation-associated urothelial cytochrome P450 oxidoreductase predicates the xenobiotic-metabolizing activity of "luminal" muscle-invasive bladder cancersSimon C Baker, Volker M Arlt, Radek Indra, et al.Molecular Carcinogenesis|January 4, 2019
Exosomal protein CD82 as a diagnostic biomarker for precision medicine for breast cancerXiaodan Wang, Weiliang Zhong, Jingya Bu, et al.Molecular Carcinogenesis|January 4, 2019
TIMM50 promotes tumor progression via ERK signaling and predicts poor prognosis of non-small cell lung cancer patientsXiupeng Zhang, Shuai Han, Haijing Zhou, et al.Pageof 414